RIPGBM
RIPGBM is a small molecule that selectively induces apoptosis in glioblastoma multiforme (GBM) cancer stem cells with an EC50 of ≤500 nM. It is a valuable research tool for studying GBM stem cell biology and has demonstrated efficacy in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
355406-76-7
Product Name Alternative
RIPGBM, Inhibitor, inhibit, Apoptosis inducer, Apoptosis, in GBM CSCs, Apoptosis
Field of Research
Cell Biology
Purity
99.45% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.67 mM) ; DMSO:30 mg/mL (70.02 mM)
Smiles
CC (=O) N (CC1=CC=C (F) C=C1) C1=C (NCC2=CC=CC=C2) C (=O) C2=C (C=CC=C2) C1=O
Molecular Formula
C26H21FN2O3
Molecular Weight
428.45
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15151647 1 Vial
Lentiviral mouse Vmn1r217 shRNA (UAS) - Lentiviral mouse Vmn1r217 shRNA (UAS, iRFP) (100)
Sign In for Pricing
View Details 
S0745-05D-AP 200 µL
SENP6, NT (SUSP1, Sentrin-specific Protease 6, Sentrin/SUMO-specific Protease SENP6, SUMO-1-specific Protease 1, KIAA0797, SSP1, FKSG6) (AP) discontinued
Sign In for Pricing
View Details